UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000020351
Receipt No. R000023512
Official scientific title of the study Efficacy and safety of trichloroacetate chemocauterization for pyriform sinus fistula
Date of disclosure of the study information 2015/12/25
Last modified on 2016/05/23 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Efficacy and safety of trichloroacetate chemocauterization for pyriform sinus fistula
Title of the study (Brief title) Trichloroacetate chemocauterization for pyriform sinus fistula
Region
Japan

Condition
Condition pyrifirm sinus fistula
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate efficacy and safety of trichloroacetate chemocauterization for pyriform sinus fistula
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes duration of recurrence-free observation
Key secondary outcomes

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 chemocauterization of internal opening of pyriform sinus fistula with 30% trichloroacetate is performed under general anesthesia
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
5 years-old <=
Age-upper limit
60 years-old >=
Gender Male and Female
Key inclusion criteria Patients who was suffered from neck abscess caused by pyriform sinus fistula
Key exclusion criteria Patients with severe renal or liver dysfunction, with a risk for general anesthesia, or whom a doctor considered not eligible
Target sample size 1

Research contact person
Name of lead principal investigator Tomokazu Yoshizaki
Organization Kanazawa University
Division name Otolaryngology-Head and Neck Surgery
Address 13-1 Takaramachi, Kanazawa, Ishikawa
TEL 076-265-2413
Email tomoy@med.kanazawa-u.ac.jp

Public contact
Name of contact person Shigeyuki Murono
Organization Kanazawa University
Division name Otolaryngology-Head and Neck Surgery
Address 13-1 Takaramachi, Kanazawa, Ishikawa
TEL 076-265-2413
Homepage URL
Email murono@med.kanazawa-u.ac.jp

Sponsor
Institute Kanazawa University
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization Otolaryngology-Head and Neck Surgery, Kanazawa University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 12 Month 25 Day

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 08 Month 01 Day
Anticipated trial start date
2013 Year 08 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 12 Month 25 Day
Last modified on
2016 Year 05 Month 23 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023512